As extracellular vesicle (EV) therapeutics progress toward clinical and commercial applications, developers face increasing challenges around characterization, process control, scalability, and regulatory readiness. Establishing a robust analytical and manufacturing strategy early can help ensure product consistency, accelerate development, and support long-term success.
This white paper explores a science-driven framework for EV characterization, providing practical insights into the analytical techniques, functional assays, and process development approaches that enable the advancement of high-quality EV therapeutics.
Key Takeaways
- Develop a structured approach to EV characterization across physical, molecular, and functional attributes.
- Understand how analytical data can support product identity, potency, and quality assessments.
- Explore strategies for distinguishing EVs from non-vesicular particles and contaminants.
- Learn how potency and functional assays can provide meaningful biological insights.
- Discover process development considerations for improving yield, consistency, and manufacturability.
- Review scalable upstream and downstream manufacturing approaches for clinical and commercial production.
- Gain insight into emerging EV engineering techniques and evolving regulatory expectations.
Why This White Paper Matters
The successful development of EV-based therapeutics depends on more than biological promise alone. Developers must establish rigorous characterization strategies and robust manufacturing processes that can deliver reproducible products at scale while meeting regulatory expectations.
Through real-world analytical and process development examples, this paper highlights how a disciplined, attribute-driven approach can help organizations make data-driven decisions, reduce development risk, and build a stronger foundation for clinical success.
Who Should Read This?
- Cell and gene therapy developers
- Process development scientists
- Analytical development teams
- CMC and manufacturing leaders
- Translational and preclinical researchers
- Organizations developing EV or exosome-based therapeutics
Featured Topics
- EV characterization frameworks
- Nanoparticle and molecular analysis methods
- Potency and functional assay development
- Process optimization and scale-up strategies
- Purification and manufacturing considerations
- Extracellular vesicle engineering approaches
- Regulatory and quality considerations
Download the White Paper
Learn how a comprehensive characterization and process development strategy can support the creation of reproducible, scalable, and regulatory-ready extracellular vesicle therapeutics.
Complete the form to access your copy of Characterizing Extracellular Vesicles Across Analytical and Process Development.
